Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.5%
5Y CAGR+10.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+24.5%/yr
vs +21.6%/yr prior
5Y CAGR
+10.2%/yr
Recent acceleration
Acceleration
+2.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $43.58M | +67.6% |
| 2024 | $26.01M | +16.9% |
| 2023 | $22.25M | -1.4% |
| 2022 | $22.58M | +9.1% |
| 2021 | $20.70M | -22.9% |
| 2020 | $26.86M | +40.6% |
| 2019 | $19.11M | +85.1% |
| 2018 | $10.32M | +44.6% |
| 2017 | $7.14M | - |